These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2261677)

  • 1. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac dysfunction caused by factors released from endotoxin-activated macrophages.
    Salari H; Walker MJ
    Circ Shock; 1989 Mar; 27(3):263-72. PubMed ID: 2706756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of platelet-activating factor in conscious, normotensive endotoxemia.
    Ephgrave K; Kremer T; Broadhurst K; Cullen J
    J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of platelet-activating factor on isolated rat hearts.
    Pugsley MK; Salari H; Walker MJ
    Circ Shock; 1991 Dec; 35(4):207-14. PubMed ID: 1663843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
    Stahl GL; Lefer AM
    Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C; Guc MO; Furman BL; Parratt JR
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig.
    Bernat A; Herbert JM; Salel V; Lespy L; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):41-8. PubMed ID: 1391738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vascular response to platelet-activating factor in the perfused rat heart.
    Man RY; Hu W; Kinnaird AA
    J Lipid Mediat; 1990; 2(2):75-83. PubMed ID: 2135670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adrenal steroids in the recovery from platelet activating factor challenge.
    Myers AK; Bader TJ
    Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
    Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
    Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
    J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
    Li SH; Fei X; Gong XQ; Wu ZL
    Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.